Rhythm Pharmaceuticals buy Royal Bank of Canada
Start price
06.05.26
/
50%
€81.00
Target price
06.05.27
€116.89
Performance (%)
-6.79%
Price
09:32
?
Summary
This prediction is currently active. With a performance of -6.79%, the BUY prediction for Rhythm Pharmaceuticals by Royal_Bank_of_Canada is down slightly. This prediction currently runs until 06.05.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Rhythm Pharmaceuticals | -1.333% | -1.333% |
| iShares Core DAX® | -2.195% | 0.670% |
| iShares Nasdaq 100 | -2.629% | 2.992% |
| iShares Nikkei 225® | -2.021% | 3.141% |
| iShares S&P 500 | -1.670% | 2.405% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals (RYTM) had its price target raised by Royal Bank Of Canada from $136.00 to $137.00. They now have an "outperform" rating on the stock.
Ratings data for RYTM provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€77.50
17.03.26
17.03.26
€113.07
17.03.27
17.03.27
-3.87%
09:32
09:32
